148 related articles for article (PubMed ID: 38314885)
1. Efficacy of lubiprostone for functional constipation treatment in adolescents and children: Randomized controlled trial.
Elkaragy ES; Shamseya MM; Metwally RH; Mansour ER; Lashen SA
J Pediatr Gastroenterol Nutr; 2024 Apr; 78(4):800-809. PubMed ID: 38314885
[TBL] [Abstract][Full Text] [Related]
2. Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).
Gordon M; Naidoo K; Akobeng AK; Thomas AG
Evid Based Child Health; 2013 Jan; 8(1):57-109. PubMed ID: 23878124
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of lubiprostone in patients with chronic constipation.
Barish CF; Drossman D; Johanson JF; Ueno R
Dig Dis Sci; 2010 Apr; 55(4):1090-7. PubMed ID: 20012484
[TBL] [Abstract][Full Text] [Related]
4. Lubiprostone Is Effective in the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Li F; Fu T; Tong WD; Liu BH; Li CX; Gao Y; Wu JS; Wang XF; Zhang AP
Mayo Clin Proc; 2016 Apr; 91(4):456-68. PubMed ID: 27046523
[TBL] [Abstract][Full Text] [Related]
5. Lubiprostone for the treatment of functional constipation in children.
Hyman PE; Di Lorenzo C; Prestridge LL; Youssef NN; Ueno R
J Pediatr Gastroenterol Nutr; 2014 Mar; 58(3):283-91. PubMed ID: 24048162
[TBL] [Abstract][Full Text] [Related]
6. Osmotic and stimulant laxatives for the management of childhood constipation.
Gordon M; Naidoo K; Akobeng AK; Thomas AG
Cochrane Database Syst Rev; 2012 Jul; (7):CD009118. PubMed ID: 22786523
[TBL] [Abstract][Full Text] [Related]
7. Osmotic and stimulant laxatives for the management of childhood constipation.
Gordon M; MacDonald JK; Parker CE; Akobeng AK; Thomas AG
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD009118. PubMed ID: 27531591
[TBL] [Abstract][Full Text] [Related]
8. Lubiprostone for Pediatric Functional Constipation: Randomized, Controlled, Double-Blind Study With Long-term Extension.
Benninga MA; Hussain SZ; Sood MR; Nurko S; Hyman P; Clifford RA; O'Gorman M; Losch-Beridon T; Mareya S; Lichtlen P; Di Lorenzo C
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):602-610.e5. PubMed ID: 33838349
[TBL] [Abstract][Full Text] [Related]
9. Real-World Comparison of Elobixibat and Lubiprostone Treatment in Patients with Chronic Constipation: A Propensity Score-Matched Analysis.
Eguchi T; Yoshizaki T; Ikeoka S; Takagi M; Fujinami M; Matsuda T; Yamaguchi T; Nonaka T; Amioka S; Katayama N; Inoue K; Matsumoto M; Momose K; Sako T; Noda M; Morisawa T; Okada A
Dig Dis; 2021; 39(4):341-350. PubMed ID: 33142288
[TBL] [Abstract][Full Text] [Related]
10. A Randomized, Double-Blind, Placebo-Controlled Trial to Examine the Effectiveness of Lubiprostone on Constipation Symptoms and Colon Transit Time in Diabetic Patients.
Christie J; Shroff S; Shahnavaz N; Carter LA; Harrison MS; Dietz-Lindo KA; Hanfelt J; Srinivasan S
Am J Gastroenterol; 2017 Feb; 112(2):356-364. PubMed ID: 27922028
[TBL] [Abstract][Full Text] [Related]
11. American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation.
Chang L; Chey WD; Imdad A; Almario CV; Bharucha AE; Diem S; Greer KB; Hanson B; Harris LA; Ko C; Murad MH; Patel A; Shah ED; Lembo AJ; Sultan S
Gastroenterology; 2023 Jun; 164(7):1086-1106. PubMed ID: 37211380
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis.
Luthra P; Camilleri M; Burr NE; Quigley EMM; Black CJ; Ford AC
Lancet Gastroenterol Hepatol; 2019 Nov; 4(11):831-844. PubMed ID: 31474542
[TBL] [Abstract][Full Text] [Related]
13. Interventions for preventing postpartum constipation.
Turawa EB; Musekiwa A; Rohwer AC
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD011625. PubMed ID: 26387487
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of lubiprostone for the treatment of functional constipation in Chinese adult patients: A multicenter, randomized, double-blind, placebo-controlled trial.
Xiao YL; Dai N; He SX; Tian A; Liu S; Tian ZB; Wang XY; Li YQ; Hou XH; Fang XC; Wen ZL; Zeng WZ; Xu H; Sun MJ; Liu YL; Wu YD; Shen XZ; Liu XW; Liu L; Chen MH
J Dig Dis; 2021 Nov; 22(11):622-629. PubMed ID: 34633753
[TBL] [Abstract][Full Text] [Related]
15. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation.
Johanson JF; Morton D; Geenen J; Ueno R
Am J Gastroenterol; 2008 Jan; 103(1):170-7. PubMed ID: 17916109
[TBL] [Abstract][Full Text] [Related]
16. Long term treatment with stimulant laxatives - clinical evidence for effectiveness and safety?
Noergaard M; Traerup Andersen J; Jimenez-Solem E; Bring Christensen M
Scand J Gastroenterol; 2019 Jan; 54(1):27-34. PubMed ID: 30700194
[TBL] [Abstract][Full Text] [Related]
17. Lubiprostone Accelerates Intestinal Transit and Alleviates Small Intestinal Bacterial Overgrowth in Patients With Chronic Constipation.
Sarosiek I; Bashashati M; Alvarez A; Hall M; Shankar N; Gomez Y; McCallum RW; Sarosiek J
Am J Med Sci; 2016 Sep; 352(3):231-8. PubMed ID: 27650225
[TBL] [Abstract][Full Text] [Related]
18. Lubiprostone vs Senna in postoperative orthopedic surgery patients with opioid-induced constipation: a double-blind, active-comparator trial.
Marciniak CM; Toledo S; Lee J; Jesselson M; Bateman J; Grover B; Tierny J
World J Gastroenterol; 2014 Nov; 20(43):16323-33. PubMed ID: 25473191
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and safety of lubiprostone after switching from stimulant laxatives in elderly patients with chronic constipation.
Maruyama M; Miida S; Sato T; Kimura T; Watanabe A; Watanabe H; Nishizawa M; Horikawa K; Kajiwara T; Karasawa Y; Hasebe Y; Nozawa K; Terai S
JGH Open; 2023 Sep; 7(9):610-617. PubMed ID: 37744709
[TBL] [Abstract][Full Text] [Related]
20. American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation.
Chang L; Chey WD; Imdad A; Almario CV; Bharucha AE; Diem S; Greer KB; Hanson B; Harris LA; Ko C; Murad MH; Patel A; Shah ED; Lembo AJ; Sultan S
Am J Gastroenterol; 2023 Jun; 118(6):936-954. PubMed ID: 37204227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
